AIBOTICS, INC.

Previous wording

We had revenue and cost of revenue from operations for the nine months ended September 30, 2025, of $2,183, as compared to $0 revenue and cost of revenue from operations for the nine months ended September 30, 2024.

Current wording

We did not have revenue and cost of revenue from operations for the three months ended March 31, 2026, as compared to $2,183 in revenue and cost of revenue from operations for the three months ended March 31, 2025.

Previous wording

Operating expenses for the three months ended September 30, 2025 and 2024 consisted solely of general and administrative expenses. For the three months ended September 30, 2025, general and administrative expenses increased by $95,108, or 25%, compared to the same period in 2024, from $385,257 to $480,365. The increase was primarily attributed to $119,372 in consulting fees, $15,000 in board compensation fees, $16,878 in advertising and marketing expenses offset by a decrease of $70,700 in product development expense.

Current wording

Operating expenses for the three months ended March 31, 2026 and 2025, consisted solely of general and administrative expenses. General and administrative expenses consisted primarily of consulting fees, stock-based compensation, board compensation, and legal and professional services. For the three months ended March 31, 2026 compared to the three months ended March 31, 2025 our general and administrative expense decreased by $172,184, or 32%, from $531,647 to $359,463. The decrease in general and administrative expenses was primarily the result of decreased legal & professional services of $15,138, a decrease in product development expense of $156,372, a decrease in consulting fees of $6,646, a decrease in other business expenses of $4,603, offset by an increase in other general and administrative expenses of $10,575.

Previous wording

Other expense for the three months ended September 30, 2025 and 2024 were composed of interest expense and loss on extinguishment of liabilities.

Current wording

Other expense for the three months ended March 31, 2026 and 2025 was composed of interest expense.

Previous wording

For the three months ended September 30, 2025 and 2024 we had a net loss of $529,921 and $460,144, respectively.

Current wording

For the three months ended March 31, 2026 and 2025 we had a net loss of $418,105 and $591,397, respectively.

Previous wording

Liquidity refers to a company’s ability to generate sufficient cash to meet its short-term financial obligations. As of September 30, 2025, we had $230,470 in cash and cash equivalents, compared to $185,097 as of December 31, 2024, representing an increase of $45,373. This increase was primarily driven by cash provided by financing activities. As of September 30, 2025, we had undiscounted obligations of approximately $1.3 million related to indebtedness due within one year.

Current wording

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of March 31, 2026, we had $288,858 in cash and cash equivalents compared to $255,940 at December 31, 2025, an increase of $32,918 resulting primarily from financing activities offset by cash used in our operations. As of March 31, 2026, we had undiscounted obligations in the amount of approximately $1.3 million relating to the payment of indebtedness due within one year.

Previous wording

Our monthly operating costs averaged approximately $10,000 per month for the nine months ended September 30, 2025, excluding capital expenditure. We did not have capital expenditures during the nine months ended September 30, 2025. We plan to fund our operations with our cash on hand and additional financing.

Current wording

Our monthly operating costs averaged approximately $12,000 per month for the three months ended March 31, 2026, excluding capital expenditures. We did not have capital expenditures during the three months ended March 31, 2026. We plan to fund our operations with our cash on hand and additional financing.

Previous wording

Operating activities used net cash of $371,636 for the nine months ended September 30, 2025, as compared to using net cash of $241,776 for the nine months ended September 30, 2024. For the nine months ended September 30, 2025, cash used in operating activities was primarily driven by our net loss of $1,607,467; offset primarily by amortization expense of approximately $496,000, the gain recognized on common stock issued to settle liability of approximately $70,712, the increase in accrued interest of approximately $52,798, the increase in accounts payable and accrued expenses of approximately $484,935 and increase in accrued expenses-related of $126,000. For the nine months ended September 30, 2024, cash used in operating activities was primarily driven by our net loss of $1,356,761;

Current wording

Operating activities used net cash of $36,258 for the three months ended March 31, 2026, as compared to using net cash of $28,360 for the three months ended March 31, 2025. For the three months ended March 31, 2026, cash used in operating activities was primarily driven by our net loss of $418,105; offset primarily by amortization expense, the increase in related party accrued expenses, the increase in accrued interest, and the increase in accounts payable and accrued expenses. For the three months ended March 31, 2025, cash used in operating activities was primarily driven by our net loss of $591,397; offset primarily by amortization expense, the increase in accounts payable and accrued expenses and the increase in related party accrued expenses.

Previous wording

Investing activities used net cash of $0 for the nine months ended September 30, 2025, and 2024.

Current wording

Investing activities used net cash of $0 for the three months ended March 31, 2026, and 2025. Financing activities produced cash flows of $69,176 and $0 for the three months ended March 31, 2026, and 2025, respectively. For the three months ended March 31, 2026 financing activities were composed primarily of proceeds from convertible notes payable of $98,000 offset by $28,824 of the repayment of convertible notes payable. There were no financing cash flows during the three months ended March 31, 2025.

Previous wording

For the nine months ended September 30, 2025, the Company incurred a net loss of $1,607,467, had negative cash flows from operations of $371,636 and may incur additional future losses. At September 30, 2025, the Company had total current assets of $241,396 and total current liabilities of $4,902,572, resulting in a working capital deficit of $4,661,176. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.

Current wording

For the three months ended March 31, 2026, the Company incurred a net loss of $418,105, had negative cash flows from operations of $36,258 and may incur additional future losses. At March 31, 2026, the Company had total current assets of $331,050 and total current liabilities of $5,051,334, resulting in a working capital deficit of $4,720,284. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.